These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 29879601)
21. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
22. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951 [TBL] [Abstract][Full Text] [Related]
23. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980 [TBL] [Abstract][Full Text] [Related]
25. New generation antipsychotics for first episode schizophrenia. Rummel C; Hamann J; Kissling W; Leucht S Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012 [TBL] [Abstract][Full Text] [Related]
26. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820 [TBL] [Abstract][Full Text] [Related]
27. Self-reported side effects in children and adolescents taking risperidone. Byrne S; Walter G; Hunt G; Soh N; Cleary M; Duffy P; Crawford G; Krabman P; Concannon P; Malhi G Australas Psychiatry; 2010 Feb; 18(1):42-5. PubMed ID: 20136533 [TBL] [Abstract][Full Text] [Related]
28. Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan. Ye W; Fujikoshi S; Nakahara N; Takahashi M; Ascher-Svanum H; Ohmori T Psychiatry Clin Neurosci; 2012 Jun; 66(4):313-21. PubMed ID: 22624736 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416 [TBL] [Abstract][Full Text] [Related]
31. Sitting time, physical fitness impairments and metabolic abnormalities in people with bipolar disorder: An exploratory study. Vancampfort D; Sienaert P; Wyckaert S; De Hert M; Stubbs B; Probst M Psychiatry Res; 2016 Aug; 242():7-12. PubMed ID: 27235986 [TBL] [Abstract][Full Text] [Related]
32. Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients. Ruaño G; Goethe JW; Caley C; Woolley S; Holford TR; Kocherla M; Windemuth A; de Leon J Mol Psychiatry; 2007 May; 12(5):474-82. PubMed ID: 17199131 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. Schneider LS; Tariot PN; Dagerman KS; Davis SM; Hsiao JK; Ismail MS; Lebowitz BD; Lyketsos CG; Ryan JM; Stroup TS; Sultzer DL; Weintraub D; Lieberman JA; N Engl J Med; 2006 Oct; 355(15):1525-38. PubMed ID: 17035647 [TBL] [Abstract][Full Text] [Related]
34. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Mladsi DM; Grogg AL; Irish WD; Lopez RB; Degen K; Swann A; Nimsch CT Curr Med Res Opin; 2004 Dec; 20(12):1883-93. PubMed ID: 15701206 [TBL] [Abstract][Full Text] [Related]
35. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
36. Sedentary behaviour patterns in outpatients with severe mental illness: a cross-sectional study using objective and self-reported methods. The PsychiActive project. Bueno-Antequera J; Oviedo-Caro MÁ; Munguia-Izquierdo D Psychiatry Res; 2017 Sep; 255():146-152. PubMed ID: 28550755 [TBL] [Abstract][Full Text] [Related]
37. Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Konarzewska B; Wołczyński S; Szulc A; Galińska B; Popławska R; Waszkiewicz N Psychoneuroendocrinology; 2009 Jan; 34(1):129-39. PubMed ID: 18838228 [TBL] [Abstract][Full Text] [Related]
38. The antidepressant effects of risperidone and olanzapine in bipolar disorder. McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475 [TBL] [Abstract][Full Text] [Related]
39. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects. Boettger S; Jenewein J; Breitbart W Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793 [TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia. Yury CA; Fisher JE Psychother Psychosom; 2007; 76(4):213-8. PubMed ID: 17570959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]